background
populationbas
serolog
studi
vital
tool
understand
epidemiolog
influenza
respiratori
virus
includ
earli
assess
transmiss
sever
influenza
pandem
middl
east
respiratori
syndrom
coronaviru
howev
interpret
result
serolog
studi
hamper
divers
approach
lack
standard
method
report
object
object
consis
rosesi
statement
improv
qualiti
transpar
report
influenza
seroepidemiolog
studi
facilit
assess
valid
generaliz
publish
result
rosesi
statement
develop
expert
consensu
consis
epidemiolog
laboratori
work
group
recommend
present
familiar
format
report
guidelin
seroepidemiolog
studi
specif
type
observ
epidemiolog
studi
rosesi
statement
built
upon
strobe
guidelin
rosesi
statement
seen
extens
strobe
guidelin
rosesi
statement
present
item
use
checklist
inform
includ
result
publish
seroepidemiolog
studi
also
serv
guid
item
need
consid
studi
design
implement
hope
rosesi
statement
contribut
improv
qualiti
report
seroepidemiolog
studi
behalf
consis
steer
committe
pathogen
case
symptomat
ill
infect
detect
routin
healthcar
statist
laboratori
network
surveil
report
system
small
proport
infect
affect
popul
reli
case
incid
detect
inform
alon
lead
larg
underestim
infect
rate
overestim
sever
ill
among
gener
popul
prior
earli
stage
epidem
serolog
test
affect
popul
provid
valuabl
inform
proport
popul
low
titer
crossreact
consis
steer
committe
member
list
appendix
human
given
uncertainti
assay
perform
antibodi
kinet
expos
unexpos
popul
addit
new
immunoassay
modif
wellestablish
assay
increasingli
use
detect
influenza
viru
strainspecif
antibodi
issu
led
format
consortium
standard
influenza
seroepidemiolog
consis
consis
compris
intern
scientist
experienc
conduct
seroepidemiolog
studi
influenza
emerg
respiratori
virus
two
work
group
epidemiolog
laboratori
matter
form
provid
tool
help
standard
protocol
laboratori
method
use
see
http
consisetghnorg
aboutworkinggroupproject
overarch
goal
consis
improv
qualiti
data
aris
influenza
seroepidemiolog
studi
harmon
method
use
studi
therebi
provid
better
evid
polici
maker
guid
ration
implement
intervent
control
measur
guidelin
report
design
conduct
result
research
effect
tool
improv
qualiti
interpret
publish
data
exampl
includ
consolid
standard
report
trial
consort
strengthen
report
observ
studi
epidemiolog
strobe
guidelin
becom
instanc
wide
accept
standard
report
research
studi
expect
public
meet
standard
help
improv
design
conduct
studi
consis
prepar
follow
statement
report
seroepidemiolog
studi
influenza
rosesi
distil
experi
work
group
set
recommend
optim
report
influenza
seroepidemiolog
studi
aim
consis
rosesi
statement
improv
qualiti
transpar
report
season
avian
pandem
influenza
seroepidemiolog
studi
order
valid
generaliz
result
better
assess
statement
also
aim
improv
design
conduct
influenza
seroepidemiolog
studi
propos
report
standard
investig
consid
design
studi
consis
develop
number
protocol
guid
design
implement
seroepidemiolog
studi
protocol
avail
http
consis
tghnorgarticlesavailableconsiseinfluenzaprotocol
valuabl
resourc
consult
addit
rosesi
statement
tabl
compon
rosesi
statement
use
checklist
help
guid
key
inform
includ
result
publish
seroepidemiolog
studi
also
serv
guid
item
need
consid
studi
design
implement
report
guidelin
statement
intend
requir
framework
must
follow
content
format
also
design
instrument
assess
studi
qualiti
instrument
exist
facilit
clear
identif
studi
quantit
measur
antibodi
concentr
member
defin
popul
order
make
infer
exposur
popul
emerg
respiratori
virus
transmiss
sever
one
term
seroepidemiolog
seroepidemiolog
seropreval
seroincid
use
titl
andor
abstract
studi
mesh
term
seroepidemiolog
studi
use
keyword
rosesi
tabl
term
seroepidemiolog
seroepidemiolog
seropreval
seroincid
appli
studi
titl
abstract
medic
subject
head
seroepidemiolog
studi
use
report
populationbas
serolog
survey
explain
quantit
variabl
handl
analys
applic
describ
group
chosen
rosesi
describ
serolog
assay
limit
detect
limit
defin
calcul
describ
sampl
result
borderlin
limit
handl
analysi
rosesi
describ
justifi
titer
result
use
defin
seroposit
antibodi
titer
chang
chang
assay
result
use
defin
seroconvers
avoid
term
seroconvers
unless
refer
chang
undetect
detect
antibodi
level
otherwis
report
foldris
titer
avoid
term
infect
report
seropreval
titer
number
differ
seroepidemiolog
studi
design
use
estim
variou
measur
viru
infect
risk
differ
design
differ
strength
weak
depend
object
investig
tabl
method
section
begin
describ
studi
design
studi
popul
sampl
procedur
eg
random
conveni
sourc
serum
plasma
analyz
eg
frozen
store
vs
recent
collect
test
rational
choos
studi
design
gen
studi
close
contact
confirm
influenza
case
eg
household
contact
confirm
case
order
permit
generaliz
studi
result
prefer
studi
popul
close
possibl
gener
popul
studi
howev
alway
feasibl
exampl
mani
serolog
studi
detect
antibodi
viru
infect
conduct
use
residu
sera
blood
donor
hospit
patient
may
repres
broader
popul
locat
potenti
introduc
select
bia
studi
address
discuss
method
use
infer
cumul
incid
infect
among
popul
base
result
studi
sampl
exampl
weight
standard
report
suffici
detail
permit
reproduc
rosesi
addit
confid
result
conclus
seroepidemiolog
studi
depend
among
thing
whether
plan
studi
sampl
size
suffici
provid
estim
preval
incid
infect
suffici
precis
certainti
assess
whether
plan
sampl
size
adequ
titer
analyz
interpret
affect
result
especi
constitut
larg
proport
result
common
convent
accept
consid
result
limit
detect
serial
step
limit
start
antibodi
dilut
valu
report
five
purpos
data
analysi
rather
zero
crosssect
studi
seropreval
estim
proport
specimen
antibodi
titer
specif
threshold
confid
interv
typic
obtain
use
binomi
formula
normal
approxim
binomi
number
addit
assumpt
met
includ
seropreval
epidem
low
almost
infect
individu
rise
convalesc
antibodi
titer
chosen
threshold
postepidem
seropreval
provid
approxim
estim
cumul
incid
infect
note
seropreval
proport
rate
studi
pair
sera
cumul
incid
viru
infect
estim
proport
person
rise
antibodi
titer
tradit
fourfold
greater
rise
studi
confid
interv
typic
estim
use
binomi
formula
normal
approxim
binomi
implicitli
assum
person
experi
one
viru
infect
period
consid
noteworthi
point
also
cumul
incid
viru
infect
sometim
refer
attack
rate
although
proport
infect
may
asymptomat
therefor
attack
quantiti
measur
proport
rate
term
cumul
incid
infect
therefor
prefer
attack
rate
context
serolog
studi
either
case
method
use
account
probabl
seroposit
seroconvers
infect
method
use
account
decay
antibodi
titer
time
report
rosesi
increas
transpar
cumul
incid
infect
estim
often
help
report
unadjust
estim
distribut
antibodi
titer
age
group
rosesi
studi
particularli
complex
design
term
time
serolog
measur
improv
estim
seropreval
certain
point
time
cumul
incid
infect
specifi
time
period
may
obtain
fit
observ
data
mechanist
model
transmiss
dynam
account
nonindepend
data
rosesi
although
serum
sampl
commonli
use
serolog
studi
conveni
sampl
may
enabl
access
plasma
use
anticoagul
separ
plasma
shown
reduc
antibodi
titer
influenza
virus
antigen
antigen
equival
specif
viru
strain
studi
popul
expos
enabl
comparison
laboratori
also
aid
develop
specif
recommend
virus
recommend
use
confirmatori
serolog
assay
upon
detect
singl
serum
posit
mn
assay
confirmatori
assay
use
criteria
posit
also
need
describ
detail
rosesi
inclus
avail
intern
standard
facilit
compar
serolog
data
inclus
actual
titer
obtain
intern
standard
indic
whether
data
report
raw
valu
intern
standardadjust
valu
therefor
describ
rosesi
direct
compar
influenza
seroepidemiolog
studi
current
limit
lack
standard
across
studi
